PharmiWeb.com - Global Pharma News & Resources
25-Oct-2018

Thirteen Company Announces Availability Of Data Analytics Services For The Aesthetic Industry And Investors

Thirteen Company Announces Availability Of Data Analytics Services For The Aesthetic Industry And Investors Thirteen Company Provides Real Time Data From Aesthetic Medical Practices In The United States. De-Identified Data Is Available For Products And Services Delivered By Aesthetic Medical Practices. Accurate Analytics Or Raw Data Showing Trends For Products, Age And Sex Of Patient And Geography.

PR Newswire

FORT WORTH, Texas, Oct. 25, 2018

FORT WORTH, Texas, Oct. 25, 2018 /PRNewswire/ -- Thirteen Company, the premier data aggregation and analysis provider gives pharmaceuticals, manufacturers, sales organizations, epidemiology and investors the most comprehensive data available to maximize their relevance and revenue.

Thirteen Company provides current, high-volume and deidentified data to companies and investors working in the aesthetic medical field, enabling them to have critical insights into the primary trends and drivers in the U.S. marketplace with results that can enhance their marketing efforts and bottom line in real-time.

Thirteen Company currently offers over 20 million records which track over 250 aesthetic medical products and procedures and gives them the ability to parse this data by age, gender and zip code in an annual, subscription-based service.

By providing businesses with comprehensive data along with powerful and meaningful analytics tools, Thirteen Company gives them the ability to make the most informed decisions possible, giving them greater relevance in each markets, boosting customer acquisition and retention and maximizing revenue.

Marketing-decision makers can target new product offerings and campaigns around the demands of local customers, zeroing in on current market interest, while practitioners can avoid procedures which trends suggest will not support repeat customer business or retention.

Data provided by Thirteen Company is deidentified per HIPAA regulation 45 CFR ยง 164.514 and includes the following practice-critical services including:

  • Neurotoxins
  • Injectable Fillers
  • Laser & Light Devices
  • Medical Wellness & Weightloss
  • Aesthetic Skin Care Treatments
  • Aesthetic surgical procedures including breast and liposuction
  • Facelift Surgery
  • Aesthetic Eye Surgeries
  • Rhinoplasty
  • Non-surgical Body Contouring
  • Body Contouring Surgery
  • Vaginal Rejuvenation Therapy

When business employ the most current and detailed market data available along with cutting-edge analysis tools, they can extend their reach, increase their profits, and decrease their spend by better targeting their marketing dollars.

Thirteen Company is the industry leader in providing data and trend subscription services that can help drive business decisions. Through its offering of current and highly relevant data and robust analytical tools, businesses can achieve the key insights that will enable them to get the most out of their marketing initiatives and improve their bottom lines with an intuitive workflow.

Call Thirteen Company today at (817) 628-0945 to learn more about how data analytics specific to your industry can enhance your marketing decisions, increase the effectiveness of your campaigns and products and drive new and repeat business.

Media Contact:  Michael FitzMaurice, 817 628 0945, info@thirteenco.co

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/thirteen-company-announces-availability-of-data-analytics-services-for-the-aesthetic-industry-and-investors-300737477.html

SOURCE Thirteen Company

Editor Details

Last Updated: 25-Oct-2018